Exhibit 99.1 For investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024 • Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23% • Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 25, 2024 – ResMed Inc. (NYSE: RMD, ASX: RMD) today announced re ...